SightfileU.S. market data from official filings
Companies › LONA
LEONABIO INC (LONA)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001620463 · EDGAR filings · Updated 2026-07-10
LEONABIO INC (LONA) has reported institutional ownership of 68.7%, with 39 institutional managers holding positions valued at $66.0M per the latest 13F reporting period.
Institutional ownership
68.7%
Institutional managers
39
Reported 13F value
$66.0M
Insider activity
36 trans.
−$115.6K net selling
Latest updates
- 2026-07-10 — Insider transaction reported (Form 4)
- 2026-07-09 — Insider transaction reported (Form 4)
- 2026-06-24 — Insider transaction reported (Form 4)
- 2026-06-24 — Insider transaction reported (Form 4)
- 2026-06-24 — Insider transaction reported (Form 4)
- 2026-06-24 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, LEONABIO INC has 39 institutional holders and institutional ownership of 68.7%.
Insider activity
Insiders reported 36 transactions (0 buys, 15 sells) across 6 reporting insiders, with a net reported value of −$115.6K.
Related companies
IMMUNIC (IMUX) · SAGIMET BIOSCIENCES INC (SGMT) · AC IMMUNE SA (ACIU) · Unicycive Therapeutics Inc (UNCY) · LIFEMD (LFMD) · HUTCHMED CHINA LTD (HCM)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-10.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-10.